ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Psoriatic Arthritis

Measuring the Value of How a Patient “Feels”

How a patient feels may be a better indicator of the effectiveness of treatment than actual disease activity, researchers say. 
(©AlexanderRaths/Shutterstock.com)

Psoriatic Arthritis

(Psoriasis ©Artemidapsy/Shutterstock.com)

In this slideshow, we highlight a Brazilian study that examines the effects of biologics on the three most common psoriasis comorbidities: Metabolic syndrome, cardiovascular disease and fatty liver disease.

In this slideshow, we review the biologics currently approved to treat adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.

(Psoriasis ©ChristineLangerPueschel/Shutterstock.com)

The U.S. Food and Drug Administration has approved brodalumab (Siliq) for the treatment of adults and moderate-to-severe plaque psoriasis.

(©AlexanderRaths/Shutterstock.com)

How a patient feels may be a better indicator of the effectiveness of treatment than actual disease activity, researchers say.

(Plantar fascia ©MedicalArtInc/Shutterstock.com)

Clinical enthesitis is a common condition for some psoriatic arthritis patients who are disproportionately affected by inflammation, particularly of the Achilles tendon, plantar fascia and lateral epicondyle.

©SutthaBurawonk/Shutterstock.com

Psoriatic spondyloarthritis forms part of the spondyloarthritis spectrum, between peripheral-only psoriatic arthritis and ankylosing spondylitis.

Up to 30% of psoriasis patients will develop psoriatic arthritis. Studies show that a proportion of patients in clinical care have undiagnosed PsA.

Pages

Subscribe to Psoriatic Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.